Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

STSI releases Scripps Wellderly Genome Resource to explore genetic cause for certain illness

Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool - a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI).

7 Mar 2014

TAZ gene represents potential target for drug therapies to treat aggressive types of breast cancer

Significance: Understanding more about how the different types of cells in breast tissue develop improves our knowledge of breast cancer. TAZ represents a potential new target for drug therapies to treat aggressive types of breast cancer.

7 Mar 2014

New drug is effective against superbug MRSA

"I routinely call hospitals and request their yearly antibiotic susceptibility testing data," said Washington University in St. Louis' Timothy Wencewicz. "The log might say, for example, that they've treated hundreds of patients for Acinetobacter baumanni, a bacterium brought into U.S. hospitals by soldiers wounded in the Iraq war, with 30 different antibiotics.

6 Mar 2014

Metabolon agrees to provide biochemical profiling services to Human Longevity

Metabolon, Inc., the world's leading commercial-stage metabolomics company, announces the signing of an agreement with newly-launched Human Longevity Inc., whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to tackle diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database.

5 Mar 2014

Human Longevity, UC San Diego sign new collaborative research agreement

The new collaborative research agreement between Human Longevity Inc. and the University of California, San Diego, announced today, represents a significant and necessary step in efforts to research and translate the potential of the human genome into novel and real treatments and therapies able to change and improve the human condition.

5 Mar 2014

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Researchers at the Translational Genomics Research Institute have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.

5 Mar 2014

Studies identify gene signals involved with BMI and their connection to: heart disease, diabetes

Two recent genetic studies expand the list of genes involved with body fat and body mass index, and their connection to major Western health problems: heart disease, high blood pressure and diabetes.

5 Mar 2014

Two genetic studies expand list of genes connected to major Western health problems

Two recent genetic studies expand the list of genes involved with body fat and body mass index, and their connection to major Western health problems: heart disease, high blood pressure and diabetes. One study showed that higher body mass index (BMI) caused harmful effects on the risk of type 2 diabetes, high blood pressure and inflammation, while another study found gene signals linked to higher levels of body fat metrics, without showing causality.

5 Mar 2014

The Gordon & Llura Gund Foundations donates $3M to support Autism Speaks' Aut10K program

Autism Speaks, the world's leading autism science and advocacy organization, today announced that The Gordon & Llura Gund Foundation and The Gordon & Llura Gund 93 Foundation have donated a combined $3 million to support Autism Speaks' Autism Ten Thousand Genomes (Aut10K) program to sequence the world's largest collection of whole genomes of individuals with autism spectrum disorder (ASD) and their family members.

5 Mar 2014

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Beckman Coulter Life Sciences today announced an agreement with Wyatt Technology Corporation enabling collaboration on products, applications and technical development. The partnership brings together Wyatt’s expertise in protein characterization, light scattering and biophysics with Beckman Coulter’s expertise in particle counting, particle characterization and cell viability measurement.

4 Mar 2014

Oxford Gene Technology announces acquisition of Cytocell

Oxford Gene Technology, a provider of innovative genetics research solutions, today announced the acquisition of Cambridge-based Cytocell Limited, a leading provider of DNA technology for the detection of gene rearrangements related to inherited genetic disease and cancer.

From Oxford Gene Technology 4 Mar 2014

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

The incidence of autism spectrum disorders has increased sharply since it was first described 60 years ago. Today, ASD affects more than 1% of all children in the U.S. and about half of them develop a life-long disability.

3 Mar 2014

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

3 Mar 2014

New web portal to speed discovery of genes responsible for rare disorders

A new web portal - called PhenomeCentral - is being launched today to connect clinicians and scientists worldwide in an effort to speed the discovery of genes responsible for rare disorders.

3 Mar 2014

Researchers find unusual mutation strongly linked to rare liver cancer that affects teens

In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center (NYGC), an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults.

3 Mar 2014

Researcher to receive AACR- Joseph H. Burchenal Memorial Award for achievement in cancer research

John F. DiPersio, M.D., Ph.D., will be recognized with the 19th Annual American Association for Cancer Research-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research at the AACR Annual Meeting 2014, to be held in San Diego, Calif., April 5-9.

3 Mar 2014

Researchers make new advances in study of chronic lymphatic leukaemia genome

A study led by Dr. Roderic Guig- from the Centre for Genomic Regulation in Barcelona, as part of the Chronic Lymphatic Leukaemia Genome Consortium, has made new advances in the study of this disease.

3 Mar 2014

Washington University professor to receive AACR-CRI Lloyd J. Old Award in Cancer Immunology

The American Association for Cancer Research (AACR) and the Cancer Research Institute (CRI) will present Robert D. Schreiber, Ph.D., Alumni Endowed Professor of Pathology and Immunology, Professor of Molecular Microbiology, and Director of the Center for Human Immunology and Immunotherapy Programs at Washington University School of Medicine in St. Louis, Mo., with the second annual AACR-CRI Lloyd J. Old Award in Cancer Immunology at the AACR Annual Meeting 2014, to be held in San Diego, Calif., April 5-9.

3 Mar 2014

Researchers develop new web-based tool to unlock genetics behind grapevine development

University of Adelaide researchers have developed a new web-based tool to help unlock the complex genetics and biological processes behind grapevine development.

28 Feb 2014

Protein interaction network provides invaluable resource to identify targets for Huntington's disease

Researchers at the Buck Institute have identified and categorized thousands of protein interactions involving huntingtin, the protein responsible for Huntington's disease (HD). To use an analogy of a human social network, the identified proteins are like "friends" and "friends of friends" of the HD protein.

28 Feb 2014

Genomics News and Research

Further Reading

STSI releases Scripps Wellderly Genome Resource to explore genetic cause for certain illness

TAZ gene represents potential target for drug therapies to treat aggressive types of breast cancer

New drug is effective against superbug MRSA

Metabolon agrees to provide biochemical profiling services to Human Longevity

Human Longevity, UC San Diego sign new collaborative research agreement

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Studies identify gene signals involved with BMI and their connection to: heart disease, diabetes

Two genetic studies expand list of genes connected to major Western health problems

The Gordon & Llura Gund Foundations donates $3M to support Autism Speaks' Aut10K program

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Oxford Gene Technology announces acquisition of Cytocell

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

RainDance Technologies closes $16.5 million Series E financing round

New web portal to speed discovery of genes responsible for rare disorders

Researchers find unusual mutation strongly linked to rare liver cancer that affects teens

Researcher to receive AACR- Joseph H. Burchenal Memorial Award for achievement in cancer research

Researchers make new advances in study of chronic lymphatic leukaemia genome

Washington University professor to receive AACR-CRI Lloyd J. Old Award in Cancer Immunology

Researchers develop new web-based tool to unlock genetics behind grapevine development

Protein interaction network provides invaluable resource to identify targets for Huntington's disease

Sequencing & Genomics: Elevating Science and Healthcare eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo